Advertisement
Advertisement
U.S. markets open in 8 hours 4 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Genertec Universal Medical Group Company Limited (2666.HK)

HKSE - HKSE Delayed Price. Currency in HKD
3.800-0.110 (-2.81%)
As of 01:05PM HKT. Market open.
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in HKD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 10/3/2023
Current
Market Cap (intraday)
7.40B
Enterprise Value
61.05B
Trailing P/E
3.93
Forward P/E
3.96
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
0.54
Price/Book (mrq)
0.41
Enterprise Value/Revenue
4.76
Enterprise Value/EBITDA
18.58

Trading Information

Stock Price History

Beta (5Y Monthly) 0.71
52-Week Change 3-5.33%
S&P500 52-Week Change 313.11%
52 Week High 35.400
52 Week Low 33.220
50-Day Moving Average 34.034
200-Day Moving Average 34.525

Share Statistics

Avg Vol (3 month) 33.18M
Avg Vol (10 day) 31.98M
Shares Outstanding 51.89B
Implied Shares Outstanding 61.89B
Float 8898.12M
% Held by Insiders 155.36%
% Held by Institutions 14.56%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.34
Forward Annual Dividend Yield 48.70%
Trailing Annual Dividend Rate 30.30
Trailing Annual Dividend Yield 37.70%
5 Year Average Dividend Yield 45.78
Payout Ratio 433.83%
Dividend Date 3N/A
Ex-Dividend Date 4Jun 09, 2023
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Jun 30, 2023

Profitability

Profit Margin 15.75%
Operating Margin (ttm)21.47%

Management Effectiveness

Return on Assets (ttm)2.61%
Return on Equity (ttm)11.09%

Income Statement

Revenue (ttm)12.53B
Revenue Per Share (ttm)6.62
Quarterly Revenue Growth (yoy)17.30%
Gross Profit (ttm)4.14B
EBITDA N/A
Net Income Avi to Common (ttm)1.89B
Diluted EPS (ttm)1.000
Quarterly Earnings Growth (yoy)1.00%

Balance Sheet

Total Cash (mrq)3.13B
Total Cash Per Share (mrq)1.65
Total Debt (mrq)53.57B
Total Debt/Equity (mrq)272.12%
Current Ratio (mrq)2.56
Book Value Per Share (mrq)8.88

Cash Flow Statement

Operating Cash Flow (ttm)38.41M
Levered Free Cash Flow (ttm)N/A
Advertisement
Advertisement